The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial
NCT: NCT06924086 · RECRUITING
Brief Summary
The CADET Trial will investigate the effectiveness of deep brain stimulation (DBS) to reduce the frequency of seizures in children with Lennox-Gastaut syndrome (LGS). The CADET Trial will use a non-CE/UKCA marked device - the Picostim DBS system. The SMART-DBS study is a sub-study of the CADET Trial. SMART-DBS will investigate the application of adaptive DBS for the treatment of children with LGS. Children will be recruited after they exit from either the prior 'CADET Pilot Study' or 'CADET Trial' - meaning that these children will already be receiving therapy with an already implanted Picostim device.
Frequently Asked Questions
What is The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial?
The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial is a clinical trial registered under NCT06924086. Current status: RECRUITING.
What is the status of NCT06924086?
The current status of NCT06924086 (The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial) is: RECRUITING.
When did The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial start?
The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial started on 2026-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.